Symbiotec Pharmalab Limited IPO

The company derives almost all of its revenue from the sale of APIs, which collectively constituted 100.00%, 99.10%, 100.00% and 100.00% of the company's revenue from operations in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Further, the company's top five APIs constituted 65.11%, 63.16%, 60.37% and 66.36% of its revenue from operations in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Any reduction in demand for APIs, and the company's top products in particular, could have an adverse effect on its business, results of operations, financial condition and cash flows.

The company's manufacturing facilities are subject to periodic inspections and audits by regulatory authorities and its customers. Any manufacturing or quality control failures may subject it to regulatory action, damage the company reputation and have an adverse effect on its business, results of operations, financial condition and cash flows.

The company export the company's products to various countries and its revenue from external customers outside India as per Ind AS 108 - "Operating Segments" represented 66.67%, 55.19%, 59.97%, and 52.76% of the company's revenue from operations in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. The company's inability to handle risks associated with its export sales could adversely affect its sales to customers in foreign countries, the company's results of operations, financial condition and cash flows.

In the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, revenue from the United States represented 11.61%, 4.02%, 8.97%, and 4.39% of the company's revenue from operations. The imposition of tariffs or other anti-outsourcing legislation by the United States could adversely affect the company's results of operations, financial condition and cash flows.

The company derives a substantial portion of its revenue from certain key customers. Revenue generated from the company's top ten customers accounted for 64.01%, 55.90%, 61.65% and 60.65% of its revenue from sale of product except one-off item in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Loss of the company's relationship with any of these customers or delays or reductions in their orders could have an adverse effect on its business, results of operations, financial condition and cash flows.

The company's manufacturing facilities are located in the state of Madhya Pradesh in India. Any adverse developments affecting Madhya Pradesh or its surrounding regions could adversely affect the company's business, results of operations, financial condition and cash flows. A slowdown, interruption or shutdown in its manufacturing operations could have an adverse effect on the company's business, results of operations, financial condition and cash flows.

The company depend on certain suppliers for raw materials for its operations. Purchases from the company's top ten suppliers accounted for 17.90%, 18.41%, 50.33% and 34.95% of its total expenses in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Any loss of such suppliers or nonperformance of their obligations could adversely affect the company's business, results of operations, financial condition and cash flows.

The company's procure a portion of its raw material requirements from different countries, including China and the United States. Any adverse developments in these countries, or the laws governing our imports from these countries, could disrupt our raw material supply and adversely affect its results of operations, financial condition and cash flows.

The company's success depends on its ability to develop and commercialise new products in a timely manner. If the company's research and development efforts do not succeed, or the products the company commercialise do not perform as expected, the introduction of new products may be hindered, which could adversely affect its business, results of operations, financial condition and cash flows.

The company's operations involve activities and materials which are hazardous in nature and could result in a suspension of operations, injury to the company's personnel, emission of pollutants or the imposition of civil or criminal liabilities, which could adversely affect its business, results of operations, financial condition and cash flows.